Multiple Beneficial Effects of Ghrelin Agonist, HM01 on Homeostasis Alterations in 6-Hydroxydopamine Model of Parkinson’s Disease in Male Rats

Background and objective: Developing therapy for non-motor symptoms of Parkinson’s disease (PD) is important for improving patients’ quality of life. Previously, we reported that the ghrelin receptor agonist, HM01 normalized the decreased 4-h fecal output and levodopa-inhibited gastric emptying in 6...

Descripción completa

Detalles Bibliográficos
Autores principales: Minalyan, Artem, Gabrielyan, Lilit, Pietra, Claudio, Taché, Yvette, Wang, Lixin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6474391/
https://www.ncbi.nlm.nih.gov/pubmed/31031602
http://dx.doi.org/10.3389/fnint.2019.00013

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6474391/
https://www.ncbi.nlm.nih.gov/pubmed/31031602
http://dx.doi.org/10.3389/fnint.2019.00013

Ejemplares similares